Your browser doesn't support javascript.
loading
Hepcidin levels and gastric cancer risk in the EPIC-EurGast study.
Jakszyn, Paula; Fonseca-Nunes, Ana; Lujan-Barroso, Leila; Aranda, Núria; Tous, Mónica; Arija, Victoria; Cross, Amanda; Bueno-de-Mesquita, H B As; Weiderpass, Elisabete; Kühn, Tilman; Kaaks, Rudolf; Sjöberg, Klas; Ohlsson, Bodil; Tumino, Rosario; Palli, Domenico; Ricceri, Fulvio; Fasanelli, Francesca; Krogh, Vittorio; Mattiello, Amalia; Jenab, Mazda; Gunter, Marc; Perez-Cornago, Aurora; Khaw, Kay-Tee; Tjønneland, Anne; Olsen, Anja; Overvad, Kim; Trichopoulou, Antonia; Peppa, Eleni; Vasilopoulou, Effie; Boeing, Heiner; Sánchez-Cantalejo, Emilio; Huerta, José María; Dorronsoro, Miren; Barricarte, Aurelio; Quirós, José Maria; Peeters, Petra H; Agudo, Antonio.
Afiliação
  • Jakszyn P; Unit of Nutrition and Cancer, Catalan Institute of Oncology-ICO, IDIBELL, L'Hospitalet De Llobregat, Barcelona, Spain.
  • Fonseca-Nunes A; Unit of Nutrition and Cancer, Catalan Institute of Oncology-ICO, IDIBELL, L'Hospitalet De Llobregat, Barcelona, Spain.
  • Lujan-Barroso L; Unit of Nutrition and Cancer, Catalan Institute of Oncology-ICO, IDIBELL, L'Hospitalet De Llobregat, Barcelona, Spain.
  • Aranda N; Department of Nursing of Public Health, Mental Health and Maternity and Child Health School of Nursing Universitat de Barcelona,Spain.
  • Tous M; Nutrition and Public Health Unit, Faculty of Medicine and Health Sciences, Research Group in Nutrition and Mental Health (NUTRISAM), Institut d'investigació Sanitària Pere Virgili (IISPV), Universitat Rovira i Virgili (URV), Reus, Tarragona, Spain.
  • Arija V; Nutrition and Public Health Unit, Faculty of Medicine and Health Sciences, Research Group in Nutrition and Mental Health (NUTRISAM), Institut d'investigació Sanitària Pere Virgili (IISPV), Universitat Rovira i Virgili (URV), Reus, Tarragona, Spain.
  • Cross A; Nutrition and Public Health Unit, Faculty of Medicine and Health Sciences, Research Group in Nutrition and Mental Health (NUTRISAM), Institut d'investigació Sanitària Pere Virgili (IISPV), Universitat Rovira i Virgili (URV), Reus, Tarragona, Spain.
  • Bueno-de-Mesquita HBA; Department of Epidemiology and Biostatistics, The School of Public Health, Imperial College London, United Kingdom.
  • Weiderpass E; Department of Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
  • Kühn T; Department of Gastroenterology and Hepatology, University Medical Centre, Utrecht, The Netherlands.
  • Kaaks R; Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Tromsø, Norway.
  • Sjöberg K; Department of Research, Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway.
  • Ohlsson B; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Tumino R; Genetic Epidemiology Group, Folkhälsan Research Center, Helsinki, Finland.
  • Palli D; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Foundation under Public Law, Heidelberg, Germany.
  • Ricceri F; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Foundation under Public Law, Heidelberg, Germany.
  • Fasanelli F; Department of Clinical Sciences, Lund University, Department of Gastroenterology and Nutrition, Skåne University Hospital, Malmö, Sweden.
  • Krogh V; Department of Internal Medicine, Lund University, Skane University Hospital, Malmö, Sweden.
  • Mattiello A; Cancer Registry and Histopathology Unit, "Civic - M.P. Arezzo" hospital, ASP Ragusa, Italy.
  • Jenab M; Cancer Risk Factors and Life-Style Epidemiology Unit, Cancer Research and Prevention Institute - ISPO Florence, Italy.
  • Gunter M; Unit of Epidemiology, Regional Health Service, Grugliasco, Turin, Italy.
  • Perez-Cornago A; Unit of Epidemiology, Regional Health Service, Grugliasco, Turin, Italy.
  • Khaw KT; Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
  • Tjønneland A; Department of Clinical and Experimental Medicine, Federico II University Naples, Italy.
  • Olsen A; Section of Nutrition and Metabolism, International Agency for Research on Cancer, Lyon, France.
  • Overvad K; Section of Nutrition and Metabolism, International Agency for Research on Cancer, Lyon, France.
  • Trichopoulou A; Cancer Epidemiology Unit; Nuffield Department of Population Health, University of Oxford, United Kingdom.
  • Peppa E; Department Public Health and Primary Care, University of Cambridge, United Kingdom.
  • Vasilopoulou E; Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Boeing H; Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Sánchez-Cantalejo E; Department of Public Health, Section for Epidemiology, Aarhus University, Denmark.
  • Huerta JM; Hellenic Health Foundation, Athens, Greece.
  • Dorronsoro M; WHO Collaborating Center for Nutrition and Health, Unit of Nutritional Epidemiology and Nutrition in Public Health, Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, Greece.
  • Barricarte A; Hellenic Health Foundation, Athens, Greece.
  • Quirós JM; WHO Collaborating Center for Nutrition and Health, Unit of Nutritional Epidemiology and Nutrition in Public Health, Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, Greece.
  • Peeters PH; Department of Epidemiology, German Institute of Human Nutrition, Potsdam-Rehbruecke, Nuthetal, Germany.
  • Agudo A; Escuela Andaluza de Salud Pública, Instituto de Investigación Biosanitaria ibs, Granada, Hospitales Universitarios de Granada/Universidad de Granada, Spain.
Int J Cancer ; 141(5): 945-951, 2017 09 01.
Article em En | MEDLINE | ID: mdl-28543377

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Adenocarcinoma / Hepcidinas Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Adenocarcinoma / Hepcidinas Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article